To assess molecular amylin-Aβ codeposition in human AD brains quantitatively, we developed an amylin-Aβ sandwich ELISA that relies on an anti-Aβ antibody (detection) and an anti-amylin antibody (capture) (Fig. 1D). This evidence concerns the gene IAPP and Alzheimer disease.